Trends in Mortality Due to Myocardial Infarction, Stroke, and Pulmonary Embolism in Patients Receiving Dialysis.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
entrez:
18
4
2022
pubmed:
19
4
2022
medline:
21
4
2022
Statut:
epublish
Résumé
During the past decades, improvements in the prevention and management of myocardial infarction, stroke, and pulmonary embolism have led to a decline in cardiovascular mortality in the general population. However, it is unknown whether patients receiving dialysis have also benefited from these improvements. To assess the mortality rates for myocardial infarction, stroke, and pulmonary embolism in a large cohort of European patients receiving dialysis compared with the general population. In this cohort study, adult patients who started dialysis between 1998 and 2015 from 11 European countries providing data to the European Renal Association Registry were and followed up for 3 years. Data were analyzed from September 2020 to February 2022. Start of dialysis. The age- and sex-standardized mortality rate ratios (SMRs) with 95% CIs were calculated by dividing the mortality rates in patients receiving dialysis by the mortality rates in the general population for 3 equal periods (1998-2003, 2004-2009, and 2010-2015). In total, 220 467 patients receiving dialysis were included in the study. Their median (IQR) age was 68.2 (56.5-76.4) years, and 82 068 patients (37.2%) were female. During follow-up, 83 912 patients died, of whom 7662 (9.1%) died because of myocardial infarction, 5030 (6.0%) died because of stroke, and 435 (0.5%) died because of pulmonary embolism. Between the periods 1998 to 2003 and 2010 to 2015, the SMR of myocardial infarction decreased from 8.1 (95% CI, 7.8-8.3) to 6.8 (95% CI, 6.5-7.1), the SMR of stroke decreased from 7.3 (95% CI, 7.0-7.6) to 5.8 (95% CI, 5.5-6.2), and the SMR of pulmonary embolism decreased from 8.7 (95% CI, 7.6-10.1) to 5.5 (95% CI, 4.5-6.6). In this cohort study of patients receiving dialysis, mortality rates for myocardial infarction, stroke, and pulmonary embolism decreased more over time than in the general population.
Identifiants
pubmed: 35435972
pii: 2791202
doi: 10.1001/jamanetworkopen.2022.7624
pmc: PMC9016490
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e227624Références
N Engl J Med. 2005 Jul 21;353(3):238-48
pubmed: 16034009
N Engl J Med. 1992 Sep 3;327(10):669-77
pubmed: 1386652
JAMA. 2001 Apr 4;285(13):1711-8
pubmed: 11277825
JAMA Netw Open. 2019 Mar 1;2(3):e191938
pubmed: 30874787
Med Care. 2019 Apr;57(4):262-269
pubmed: 30870384
Kidney Int. 2004 Jun;65(6):2380-9
pubmed: 15149351
N Engl J Med. 1999 Sep 9;341(11):793-800
pubmed: 10477777
N Engl J Med. 2007 Nov 15;357(20):2001-15
pubmed: 17982182
Lancet. 2002 Jul 6;360(9326):7-22
pubmed: 12114036
Am J Med. 2014 Jul;127(7):608-15
pubmed: 24680794
Lancet. 2006 May 20;367(9523):1665-73
pubmed: 16714187
Kidney Int. 2020 Oct;98(4):999-1008
pubmed: 32569654
N Engl J Med. 2012 Apr 5;366(14):1287-97
pubmed: 22449293
N Engl J Med. 2011 Sep 8;365(10):883-91
pubmed: 21830957
N Engl J Med. 2009 Dec 10;361(24):2342-52
pubmed: 19966341
Thromb Haemost. 2016 Jan;115(2):399-405
pubmed: 26422774
Am J Cardiol. 2015 Nov 1;116(9):1436-42
pubmed: 26409636
Nephrol Dial Transplant. 2001 Jun;16(6):1120-9
pubmed: 11390709
J Thromb Haemost. 2012 Dec;10(12):2484-93
pubmed: 22970891
N Engl J Med. 2009 Apr 2;360(14):1395-407
pubmed: 19332456
J Am Heart Assoc. 2015 Oct 12;4(10):e002460
pubmed: 26459933
Nephrol Dial Transplant. 2018 Oct 1;33(10):1794-1804
pubmed: 29361126
Lancet. 1989 Jan 28;1(8631):175-9
pubmed: 2563096
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
J Am Heart Assoc. 2018 Jun 15;7(12):
pubmed: 29907656
N Engl J Med. 2013 Feb 21;368(8):699-708
pubmed: 23216615
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Stroke. 2017 Nov;48(11):2939-2945
pubmed: 28970279
Nephrol Dial Transplant. 2012 Oct;27(10):3816-22
pubmed: 23114904
N Engl J Med. 1998 Nov 12;339(20):1415-25
pubmed: 9811916
Kidney Int. 2002 Nov;62(5):1799-805
pubmed: 12371982
J Am Coll Cardiol. 2016 Jan 19;67(2):162-170
pubmed: 26791063
Stroke. 2011 Apr;42(4):902-7
pubmed: 21330628
Circulation. 2002 Oct 22;106(17):2194-9
pubmed: 12390947
Kidney Int. 2013 Aug;84(2):353-8
pubmed: 23486524
N Engl J Med. 2011 Sep 15;365(11):981-92
pubmed: 21870978
Thromb Res. 2013 Jul;132(1):19-25
pubmed: 23725850
N Engl J Med. 2006 Jun 1;354(22):2317-27
pubmed: 16738268
Ann Intern Med. 2012 Mar 20;156(6):445-59
pubmed: 22431677
Heart. 2015 Sep;101(17):1413-21
pubmed: 25855798
J Am Soc Nephrol. 2013 Dec;24(12):1934-43
pubmed: 24136920
Perit Dial Int. 2000;20 Suppl 2:S118-20
pubmed: 10911656
Am J Kidney Dis. 2009 Sep;54(3):468-77
pubmed: 19376618
Lancet. 2001 Aug 18;358(9281):527-33
pubmed: 11520521
Am Heart J. 2017 Feb;184:37-46
pubmed: 27892885
Circulation. 2005 Jul 19;112(3):416-22
pubmed: 16009794
N Engl J Med. 2009 Sep 17;361(12):1139-51
pubmed: 19717844
Am J Kidney Dis. 2006 Jan;47(1):131-8
pubmed: 16377394
N Engl J Med. 2004 Dec 9;351(24):2481-8
pubmed: 15590950
Thromb Haemost. 2011 Dec;106(6):1046-52
pubmed: 22012181
Circulation. 2014 Mar 18;129(11):1196-203
pubmed: 24452752
N Engl J Med. 2008 Sep 18;359(12):1238-51
pubmed: 18753638
Thromb Res. 2015 Feb;135(2):334-8
pubmed: 25511577